M. Eller

发表

Pharmacokinetic profile of defibrotide in patients with renal impairment

J. Marier, P. Tocchetti, T. Marbury, 2016, Drug design, development and therapy.

Azithromycin and terfenadine: Lack of drug interaction

M. Eller, P. Colangelo, S. Harris, 1995, Clinical pharmacology and therapeutics.

Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction

M. Eller, S. Weir, A. Keung, 1998, Journal of clinical pharmacology.

Disposition and metabolism of 14C-rifapentine in healthy volunteers.

M. Eller, S. Weir, P. Toren, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Bioavailability of Azacitidine Subcutaneous Versus Intravenous in Patients With the Myelodysplastic Syndromes

G. Marcucci, M. Eller, L. Silverman, 2005, Journal of clinical pharmacology.

The relative bioavailability of two marketed controlled release diltiazem dosage forms at steady state in healthy volunteers.

M. Eller, S. Weir, T. Arumugham, 1996, Biopharmaceutics & drug disposition.

Pharmacokinetics of Terfenadine in Healthy Elderly Subjects

S. Ruberg, M. Eller, B. Mcnutt, 1992, Journal of clinical pharmacology.

Single-dose Pharmacokinetics of Rifapentine in Elderly Men

M. Eller, S. Weir, A. Keung, 1998, Pharmaceutical Research.

Absorption of minoxidil after topical application: Effect of frequency and site of application

M. Eller, A. Della-Coletta, G. J. Szpunar, 1989, Clinical pharmacology and therapeutics.

Determination of ethoxzolamide in the iris/ciliary body of the rabbit eye by high-performance liquid chromatography: comparison of tissue levels following intravenous and topical administrations.

M. Eller, R. Schoenwald, 1984, Journal of pharmaceutical sciences.

Single-Dose Pharmacokinetics of Rifapentine in Women

M. Eller, S. Weir, A. Keung, 1998, Journal of Pharmacokinetics and Biopharmaceutics.

Absence of effect of food on alprazolam absorption from sustained release tablets.

M. Eller, A. Della-Coletta, 1990, Biopharmaceutics & drug disposition.

Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans.

M. Eller, G. Thompson, M. Kenny, 1991, Journal of pharmaceutical sciences.

Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.

C. Phelps, M. Eller, R. Lewis, 1984, Archives of ophthalmology.

Absence of food effects on the pharmacokinetics of terfenadine

M. Eller, L. Yuh, B. Mcnutt, 1992, Biopharmaceutics & drug disposition.

Pharmacokinetics and Pharmacodynamics of Alprazolam Following Single and Multiple Oral Doses of a Sustained‐Release Formulation

M. Eller, J. Fleishaker, J. P. Phillips, 1989, Journal of clinical pharmacology.

Topical carbonic anhydrase inhibitors. III: Optimization model for corneal penetration of ethoxzolamide analogues.

M. Eller, R. Schoenwald, C. Barfknecht, 1985, Journal of pharmaceutical sciences.

Pharmacokinetics of Rifapentine in Subjects Seropositive for the Human Immunodeficiency Virus: a Phase I Study

R. Owens, M. Eller, D. Nicolau, 1999, Antimicrobial Agents and Chemotherapy.

Increased mortality in narcolepsy.

M. Ohayon, M. Eller, J. Black, 2014, Sleep.

In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity

K. Wilcox, J. Stables, M. Eller, 2008, Pharmacology Biochemistry and Behavior.

Single and multiple dose pharmacokinetics of rifapentine in man: part II.

M. Eller, S J Weir, S. Weir, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Relative Bioavailability of Cardizem CD and Tiazac Controlled‐Release Diltiazem Dosage Forms After Single and Multiple Dosing in Healthy Volunteers

M. Eller, S. Weir, T. Arumugham, 1998, American journal of therapeutics.

Absorption kinetics of topical clindamycin preparations.

M. Eller, J. P. Phillips, R. Smith, 1989, Biopharmaceutics & drug disposition.

Absorption kinetics of rectally and orally administered ibuprofen.

M. Eller, C. Wright, A. Della-Coletta, 1989, Biopharmaceutics & drug disposition.

The effect of food on the relative bioavailability of deflazacort

M. Eller, S. Weir, T. Arumugham, 1996, European Journal of Drug Metabolism and Pharmacokinetics.

Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A).

M. Eller, S. Weir, D. Yu, 1997, Biopharmaceutics & drug disposition.

An investigation of the dose proportionality of deflazacort pharmacokinetics.

M. Eller, S. Weir, V. Bhargava, 1996, Biopharmaceutics & drug disposition.

Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.

M. Eller, R. Schoenwald, C. Barfknecht, 1985, Journal of pharmaceutical sciences.

Topical carbonic anhydrase inhibitors.

M. Eller, R. Schoenwald, C. Barfknecht, 1984, Journal of medicinal chemistry.

Phase I, II, and III FDA Submissions

M. Eller, 2002 .

Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.

M. Eller, S. Weir, A. Keung, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.

M. Eller, T. Hanania, M. Foreman, 2009, European journal of pharmacology.

The effect of food on the bioavailability of dolasetron mesylate tablets

M. Eller, S. Weir, T. Arumugham, 1998, Biopharmaceutics & drug disposition.